NL188981C - PHARMACEUTICAL PREPARATION WITH ANTI-CANCER EFFECT, AND ANTHRACHINE DERIVATIVES SUITABLE AS AN ACTIVE SUBSTANCE THEREOF. - Google Patents

PHARMACEUTICAL PREPARATION WITH ANTI-CANCER EFFECT, AND ANTHRACHINE DERIVATIVES SUITABLE AS AN ACTIVE SUBSTANCE THEREOF.

Info

Publication number
NL188981C
NL188981C NLAANVRAGE7808475,A NL7808475A NL188981C NL 188981 C NL188981 C NL 188981C NL 7808475 A NL7808475 A NL 7808475A NL 188981 C NL188981 C NL 188981C
Authority
NL
Netherlands
Prior art keywords
anthrachine
active substance
pharmaceutical preparation
cancer effect
derivatives suitable
Prior art date
Application number
NLAANVRAGE7808475,A
Other languages
Dutch (nl)
Other versions
NL7808475A (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27542240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL188981(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US05/903,292 external-priority patent/US4138415A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NL7808475A publication Critical patent/NL7808475A/en
Application granted granted Critical
Publication of NL188981C publication Critical patent/NL188981C/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
    • G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J45/00—Ion-exchange in which a complex or a chelate is formed; Use of material as complex or chelate forming ion-exchangers; Treatment of material for improving the complex or chelate forming ion-exchange properties
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C08G59/62—Alcohols or phenols
    • C08G59/621—Phenols
    • C08G59/623—Aminophenols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/68—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
    • C08G59/686—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M1/00—Liquid compositions essentially based on mineral lubricating oils or fatty oils; Their use as lubricants
    • C10M1/08—Liquid compositions essentially based on mineral lubricating oils or fatty oils; Their use as lubricants with additives
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M133/00—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing nitrogen
    • C10M133/02—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing nitrogen having a carbon chain of less than 30 atoms
    • C10M133/04—Amines, e.g. polyalkylene polyamines; Quaternary amines
    • C10M133/12—Amines, e.g. polyalkylene polyamines; Quaternary amines having amino groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NLAANVRAGE7808475,A 1977-08-15 1978-08-15 PHARMACEUTICAL PREPARATION WITH ANTI-CANCER EFFECT, AND ANTHRACHINE DERIVATIVES SUITABLE AS AN ACTIVE SUBSTANCE THEREOF. NL188981C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US82487277A 1977-08-15 1977-08-15
US87317478A 1978-01-30 1978-01-30
US87304178A 1978-01-30 1978-01-30
US87304078A 1978-01-30 1978-01-30
US05/903,292 US4138415A (en) 1978-05-05 1978-05-05 1,4-Bis(aminoalkylamino)-anthraquinones and leuco derivatives thereof

Publications (2)

Publication Number Publication Date
NL7808475A NL7808475A (en) 1979-02-19
NL188981C true NL188981C (en) 1992-12-01

Family

ID=27542240

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7808475,A NL188981C (en) 1977-08-15 1978-08-15 PHARMACEUTICAL PREPARATION WITH ANTI-CANCER EFFECT, AND ANTHRACHINE DERIVATIVES SUITABLE AS AN ACTIVE SUBSTANCE THEREOF.

Country Status (22)

Country Link
JP (1) JPS6463556A (en)
AR (1) AR225884A1 (en)
AT (1) AT359484B (en)
AU (1) AU527103B2 (en)
BE (1) BE869688A (en)
CH (1) CH644840A5 (en)
DD (1) DD139256A5 (en)
DE (1) DE2835661A1 (en)
DK (1) DK158836C (en)
FI (1) FI70882C (en)
FR (1) FR2400504A1 (en)
GB (1) GB2004293B (en)
GR (1) GR74415B (en)
IE (1) IE47253B1 (en)
IL (1) IL55218A (en)
IT (1) IT1107773B (en)
NL (1) NL188981C (en)
NO (2) NO148777C (en)
NZ (1) NZ187989A (en)
PL (1) PL122586B1 (en)
PT (1) PT68420A (en)
SE (1) SE445996B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275009A (en) * 1979-05-29 1981-06-23 American Cyanamid Company 1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones
US4275010A (en) * 1979-10-24 1981-06-23 American Cyanamid Company 5,8-Dihydroxy-1,4-bis(guanidinylamino)anthraquinones
US4296030A (en) * 1980-04-09 1981-10-20 American Cyanamid Company Metal chelates of 1,4-bis(substituted-amino-5,8-dihydroxy-anthraquinones
US4278605A (en) * 1980-06-30 1981-07-14 American Cyanamid Company Heteroalkylenebisanthraquinones
EP0052853A1 (en) * 1980-11-24 1982-06-02 Hoechst Aktiengesellschaft Bis-aminomethyl-anthraquinone derivatives, process for their manufacture, compositions containing them and their use
EP0083683A1 (en) * 1981-10-26 1983-07-20 American Cyanamid Company Method of preparing 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and pharmaceutical compositions containing them
EP0154117B1 (en) * 1984-02-27 1989-12-27 American Cyanamid Company Use of 1,4 bis(substituted) anthrachinones for the manufacture of immunosuppresiva
EP0182135A3 (en) * 1984-11-19 1987-08-05 American Cyanamid Company Novel bis-(substituted amino) anthraquinones
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
GB9815910D0 (en) 1998-07-21 1998-09-23 Btg Int Ltd Synthetic method
ATE423767T1 (en) * 2003-12-23 2009-03-15 Somanta Ltd ANTHRAQUINONE DERIVATIVES AS AN AGAINST CANCER
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
SG172361A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Nucleoside analogs
EP2376515A1 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthesis of purine nucleosides
AR074897A1 (en) 2008-12-23 2011-02-23 Pharmasset Inc NUCLEOSID PHOSPHORAMIDATES
PT3290428T (en) 2010-03-31 2021-12-27 Gilead Pharmasset Llc Tablet comprising crystalline (s)-isopropyl 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1 (2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
DE102012203981A1 (en) * 2012-03-14 2013-09-19 Henkel Ag & Co. Kgaa Agent for dyeing and / or delustering keratin-containing fibers containing novel 1,4-diaminoanthraquinone dyes
GB201214169D0 (en) 2012-08-08 2012-09-19 Biostatus Ltd New compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1422016A (en) * 1962-10-29 1965-12-24 Oreal New anthraquinone dyes and their application to hair dye
GB1157506A (en) * 1965-09-10 1969-07-09 Ilford Ltd Anthraquinone Dye Colour Couplers and their use in Colour Photographic Materials
US3700398A (en) * 1970-07-27 1972-10-24 Du Pont Process for dyeing acid-modified nylon fibers
US3646072A (en) * 1970-07-27 1972-02-29 Du Pont Turquoise biscationic anthraquinone dyes
US4051155A (en) * 1975-12-15 1977-09-27 Allied Chemical Corporation Anthraquinone dyes

Also Published As

Publication number Publication date
SE7807987L (en) 1979-02-16
NO148777C (en) 1984-01-25
IL55218A (en) 1983-03-31
FI782481A (en) 1979-02-16
AU3877678A (en) 1980-02-14
PL209065A1 (en) 1980-01-02
PT68420A (en) 1978-09-01
FR2400504B1 (en) 1981-06-26
BE869688A (en) 1979-02-12
NO782756L (en) 1979-02-16
DE2835661A1 (en) 1979-03-01
GB2004293B (en) 1982-06-23
FR2400504A1 (en) 1979-03-16
IE47253B1 (en) 1984-02-08
JPH0217534B2 (en) 1990-04-20
DK358678A (en) 1979-02-16
DK158836B (en) 1990-07-23
DD139256A5 (en) 1979-12-19
JPS6463556A (en) 1989-03-09
AT359484B (en) 1980-11-10
NO150482C (en) 1984-10-24
AR225884A1 (en) 1982-05-14
CH644840A5 (en) 1984-08-31
DK158836C (en) 1991-01-14
DE2835661C2 (en) 1991-08-22
IT7850730A0 (en) 1978-08-14
IE781636L (en) 1979-02-15
GB2004293A (en) 1979-03-28
NO148777B (en) 1983-09-05
FI70882C (en) 1986-10-27
GR74415B (en) 1984-06-28
FI70882B (en) 1986-07-18
SE445996B (en) 1986-08-04
NZ187989A (en) 1981-07-13
PL122586B1 (en) 1982-08-31
ATA590678A (en) 1980-04-15
AU527103B2 (en) 1983-02-17
IT1107773B (en) 1985-11-25
NO150482B (en) 1984-07-16
NL7808475A (en) 1979-02-19
NO820290L (en) 1979-02-16

Similar Documents

Publication Publication Date Title
NL7802792A (en) CEFEM AND CEFAM COMPOUNDS WITH ANTIMICROBIAL ACTION, METHODS FOR THEIR PREPARATION, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7805278A (en) AMINOALKYLTHIOPHENE DERIVATIVES WITH SELECTIVE ACTION ON HISTAMINE RECEPTORS, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AS AN ACTIVE COMPONENT.
NL176670C (en) PHARMACEUTICAL PREPARATION WITH ANTIVIRAL ACTION AND FOR USE AS AN ACTIVE SUBSTANCE IN SUCH PREPARATION COMPOSITIONS.
NL188981C (en) PHARMACEUTICAL PREPARATION WITH ANTI-CANCER EFFECT, AND ANTHRACHINE DERIVATIVES SUITABLE AS AN ACTIVE SUBSTANCE THEREOF.
NL7803195A (en) HETEROCYCLICAL COMPOUNDS WITH PHARMACEUTICAL ACTIVITY, METHODS FOR THEIR PREPARATION, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL7801372A (en) NEW PHYSIOLOGICALLY ACTIVE COMPOUND AND METHOD OF PREPARING THIS BY MICROBIOLOGICAL ROAD, AND PHARMACEUTICAL PREPARATIONS WITH IMMUNOSUPPRESSIVE ACTION CONTAINING THE COMPOUND.
NL190580C (en) Substituted benzhydrylpiperidine derivatives with therapeutic activity and preparations containing these substances.
NL190664C (en) Substituted benzhydrylpiperidino derivatives with therapeutic activity and pharmaceutical preparations containing these compounds.
IT7829043A0 (en) POLYSACCHARIDE HAVING ANTI-CANCER ACTIVITY, PROCEDURE FOR ITS PRODUCTION AND ANTI-CANCER SUBSTANCE INCLUDING SAID POLYSACCHARIDE.
NL190702B (en) 4H-PYRIDO (1,2-A) PYRIMIDIN-4-ON COMPOUND WITH ANTI-ALLERGIC EFFECT, AND PHARMACEUTICAL PREPARATION THEREOF.
NL184467B (en) 6-OXO-PROSTAGLANDIN EŸ1 DERIVATIVES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
NL950027I2 (en) Alpha-halomethyl-alpha-amino acid derivatives and pharmaceutical preparation containing them.
NL187397C (en) PHARMACEUTICAL PREPARATIONS, 20,21-DINORO-BURNAMENINE COMPOUNDS THEREFOR AND METHOD FOR THEIR PREPARATION.
NL188981B (en) PHARMACEUTICAL PREPARATION WITH AN ANTI-CANCER ACTION AND ANTRAACHIN DERIVATIVES SUITABLE AS AN ACTIVE INGREDIENT THEREOF.
NL7811135A (en) DIG SUBSTITUTED PIPERAZINES, METHOD FOR THE PREPARATION THEREOF, AND MEDICINAL PRODUCTS WITH SUCH COMPOUNDS IN IT AS AN ACTIVE SUBSTANCE.
NL188944C (en) METHOD FOR PREPARING OMEGA-AMINO-KOXYBENZENE DERIVATIVES AND METHOD FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEIR USE AS AN ACTIVE COMPOUND
NL7801921A (en) PHARMACEUTICAL PREPARATIONS.
NL173273C (en) METHOD FOR PREPARING AN MEDICINAL PRODUCT WITH ANTIBIOTIC ACTION, FORMED MEDICINAL PRODUCT WITH ANTIBIOTIC ACTION, AND METHOD FOR PREPARING MEDICINAL COMPOUNDS USED AS THE ACTIVE PREPARATIONS IN QUESTION.
NL7510259A (en) URIDINE DERIVATIVE AND PHARMACEUTICAL PREPARATION.
NL190071B (en) 4-OXO-PYRIMIDO- (2,1-A) -ISOCHINOLINE DERIVATIVE WITH AN ANTI-ALLERGIC ACTIVITY, METHOD OF PREPARATION THEREOF AND PHARMACEUTICAL PREPARATION THEREOF.
NL7807940A (en) VINCAMINOL DERIVATIVES, METHOD FOR PREPARING THEREOF, AND MEDICINAL PRODUCTS BASED THEREOF, WITH VASOLILATING ACTION.
NL7808303A (en) BENZYL ALCOHOL DERIVATIVES WITH BLOOD SUGAR MIRROR REDUCED ACTION, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
NL188579C (en) 3- (TETRAZOL-5-YL) -1-AZAXANTHONE, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
NL180070C (en) THERAPEUTIC PREPARATION WITH ANTI-CANCER EFFECT.
NL7705561A (en) PHARMACEUTICAL PREPARATION AND METHODS FOR ITS PREPARATION AND USE.

Legal Events

Date Code Title Description
BT A notification was added to the application dossier and made available to the public
BT A notification was added to the application dossier and made available to the public
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BT A notification was added to the application dossier and made available to the public
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 980815